Skip to content

Camouflaged WeChat-based Intervention for Abused Women

Camouflaged WeChat Mini-program-based Intervention for Women Victims of Intimate Partner Violence: Protocol for a Pilot Mixed Methods Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07405528
Acronym
IPV
Enrollment
86
Registered
2026-02-12
Start date
2026-02-01
Completion date
2027-02-01
Last updated
2026-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Domestic Violence, Mental Health Wellness 1

Keywords

Domestic Violence, Intimate partner violence, mHealth intervention

Brief summary

Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. The overall objective of this pilot mixed methods study is to determine the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.

Detailed description

Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. Previous studies in Hong Kong and the United States provided evidence on IPV interventions among Chinese abused women; however, there is a scarcity of evidence on the use of mHealth for abused women while fully considering their safety studies on mobile technology for Chinese immigrant women victims are limited, and there lacks safe, low-cost, and evidence-based mHealth interventions for empowering and supporting women victims who immigrate to Hong Kong and face more vulnerabilities and needs. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV. This pilot mixed methods study will adopt the randomized, wait-list controlled trial with two groups (1:1 ratio), followed by in-depth interviews with participants in the WOMEN Health programme group at post-intervention. It will evaluate feasibility and acceptability as the primary outcomes and compare scores changes after 12 weeks interventions between Chinese immigrant women who are screened positive for IPV randomly assigned to receiving genuine IPV intervention and disguised healthy lifestyle intervention, and Chinese immigrant women who are screened positive for IPV in a control procedure. The wait-list control group will also receive the WOMEN Health programme after the intervention group completed the programme.

Interventions

BEHAVIORALWOMEN Health programme

(i) Empowerment (IPV information, ie, 30-min one-to-one interview, WeChat mini-program); (ii) Telephone social support (ie, weekly calls); (ⅲ) Healthy lifestyle intervention (ie, healthy lifestyle information and discussion)

(i) Healthy lifestyle intervention (ie, discussion and weekly calls for body weight)

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

1. Chinese-speaking (Mandarin or Cantonese) 2. women aged 18 to 45 years 3. originally from mainland China and have moved to Hong Kong for at least one year 4. screened positive for IPV during heterosexual relationships in the past year 5. have a smartphone with WeChat installed 6. with no plans to move outside Hong Kong in the next one year

Exclusion criteria

1. unwilling to provide informed consent 2. severe chronic diseases (e.g., cancer, heart failure, kidney failure, chronic obstructive pulmonary disease, and HIV/AIDS) 3. currently experience severe IPV (identified using the revised 11-item Danger Assessment)

Design outcomes

Primary

MeasureTime frameDescription
Feasibility and acceptability of the WOMEN Health programmeWeek 12Feasibility and acceptability will be assessed using a 12-item self-developed questionnaire. Items are rated on a 5-point Likert scale (1-5), with higher scores indicating greater acceptability, satisfaction, and usefulness.

Secondary

MeasureTime frameDescription
Changes in depressive symptomsBaseline and Week 12Depressive symptoms will be assessed using the Chinese version of the Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire measuring depressive symptoms experienced over the past two weeks. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms.
Changes in quality of lifeBaseline and Week 12Quality of life will be assessed using the Chinese version of the 12-Item Short Form Health Survey, version 2 (SF-12v2), which measures physical and mental health status. Physical Component Summary (PCS) and Mental Component Summary (MCS) scores range from 0 to 100, with higher scores indicating better quality of life.
Changes in intimate partner violence (IPV)Baseline and Week 12Intimate partner violence will be assessed using the Chinese version of the Revised Conflict Tactics Scales (CTS2), which measures the frequency and severity of psychological aggression, physical assault, sexual coercion, and injury within intimate relationships. Higher scores indicate greater exposure to intimate partner violence.
Changes in Body Mass Index (BMI)Baseline and up to 12 weeksBody weight will be self-measured by participants at home in the morning under fasting conditions, wearing light clothing and without shoes. Height will be measured at baseline using a wall-mounted stadiometer. BMI will be calculated as body weight in kilograms divided by height in meters squared (kg/m²) and categorized according to the World Health Organization (WHO) recommendations for Asian populations.
Changes in healthy behaviorsBaseline and Week 12Healthy lifestyle behaviors, including physical activity and dietary behaviors, will be documented by self-report data

Countries

China

Contacts

CONTACTQuanlei Li
qli1@hku.hk+852 39177577

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026